Literature DB >> 12657658

Catechol-O-methyltransferase genotype and dopamine regulation in the human brain.

Mayada Akil1, Bhaskar S Kolachana, Debora A Rothmond, Thomas M Hyde, Daniel R Weinberger, Joel E Kleinman.   

Abstract

A functional polymorphism in the gene for catechol-O-methyltransferase (COMT) has been shown to affect executive cognition and the physiology of the prefrontal cortex in humans, probably by affecting prefrontal dopamine signaling. The COMT valine allele, associated with relatively poor prefrontal function, is also a gene that may increase risk for schizophrenia. Although poor performance on executive cognitive tasks and abnormal prefrontal function are characteristics of schizophrenia, so is psychosis, which has been related to excessive presynaptic dopamine activity in the striatum. Studies in animals have shown that diminished prefrontal dopamine neurotransmission leads to upregulation of striatal dopamine activity. We measured tyrosine hydroxylase (TH) mRNA in mesencephalic dopamine neurons in human brain and found that the COMT valine allele is also associated with increased TH gene expression, especially in neuronal populations that project to the striatum. This indicates that COMT genotype is a heritable aspect of dopamine regulation and it further explicates the mechanism by which the COMT valine allele increases susceptibility for psychosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12657658      PMCID: PMC6742018     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  68 in total

Review 1.  Gating of information flow within the limbic system and the pathophysiology of schizophrenia.

Authors:  A A Grace
Journal:  Brain Res Brain Res Rev       Date:  2000-03

2.  Increased baseline occupancy of D2 receptors by dopamine in schizophrenia.

Authors:  A Abi-Dargham; J Rodenhiser; D Printz; Y Zea-Ponce; R Gil; L S Kegeles; R Weiss; T B Cooper; J J Mann; R L Van Heertum; J M Gorman; M Laruelle
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

3.  Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles.

Authors:  M A Palmatier; A M Kang; K K Kidd
Journal:  Biol Psychiatry       Date:  1999-08-15       Impact factor: 13.382

4.  The relationship between dorsolateral prefrontal neuronal N-acetylaspartate and evoked release of striatal dopamine in schizophrenia.

Authors:  A Bertolino; A Breier; J H Callicott; C Adler; V S Mattay; M Shapiro; J A Frank; D Pickar; D R Weinberger
Journal:  Neuropsychopharmacology       Date:  2000-02       Impact factor: 7.853

5.  Projections from the rat prefrontal cortex to the ventral tegmental area: target specificity in the synaptic associations with mesoaccumbens and mesocortical neurons.

Authors:  D B Carr; S R Sesack
Journal:  J Neurosci       Date:  2000-05-15       Impact factor: 6.167

Review 6.  Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors.

Authors:  P T Männistö; S Kaakkola
Journal:  Pharmacol Rev       Date:  1999-12       Impact factor: 25.468

Review 7.  The role of endogenous sensitization in the pathophysiology of schizophrenia: implications from recent brain imaging studies.

Authors:  M Laruelle
Journal:  Brain Res Brain Res Rev       Date:  2000-03

8.  Striatal dopamine receptors and transporters in monkeys with neonatal temporal limbic damage.

Authors:  A Heinz; R C Saunders; B S Kolachana; D W Jones; J G Gorey; J Bachevalier; D R Weinberger
Journal:  Synapse       Date:  1999-05       Impact factor: 2.562

9.  Family-based linkage disequilibrium mapping using SNP marker haplotypes: application to a potential locus for schizophrenia at chromosome 22q11.

Authors:  T Li; D Ball; J Zhao; R M Murray; X Liu; P C Sham; D A Collier
Journal:  Mol Psychiatry       Date:  2000-01       Impact factor: 15.992

10.  Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects.

Authors:  M Akil; J N Pierri; R E Whitehead; C L Edgar; C Mohila; A R Sampson; D A Lewis
Journal:  Am J Psychiatry       Date:  1999-10       Impact factor: 18.112

View more
  106 in total

1.  Association of Catechol-O-methyltransferase val/met polymorphism with cognitive function in Gilles de la Tourette syndrome patients.

Authors:  Weidong Ji; Ning Li; Kang Ju; Hong Zheng; Chuang Yang; Ping Xu; Silu Chen; Aiai Cao; Xue Chen; Lanting Guo
Journal:  Neurol Sci       Date:  2014-11-04       Impact factor: 3.307

Review 2.  Postmortem investigations of the pathophysiology of schizophrenia: the role of susceptibility genes.

Authors:  William R Perlman; Cynthia Shannon Weickert; Mayada Akil; Joel E Kleinman
Journal:  J Psychiatry Neurosci       Date:  2004-07       Impact factor: 6.186

Review 3.  [Genetic and pharmacological effects on prefrontal cortical function in schizophrenia].

Authors:  Andreas Heinz; Dieter F Braus; Berenice Romero; Jürgen Gallinat; Imke Puls; Georg Juckel; Daniel R Weinberger
Journal:  Nervenarzt       Date:  2004-09       Impact factor: 1.214

Review 4.  Legalization, decriminalization & medicinal use of cannabis: a scientific and public health perspective.

Authors:  Dragan M Svrakic; Patrick J Lustman; Ashok Mallya; Taylor Andrea Lynn; Rhonda Finney; Neda M Svrakic
Journal:  Mo Med       Date:  2012 Mar-Apr

5.  DAT1 and COMT effects on delay discounting and trait impulsivity in male adolescents with attention deficit/hyperactivity disorder and healthy controls.

Authors:  Yannis Paloyelis; Philip Asherson; Mitul A Mehta; Stephen V Faraone; Jonna Kuntsi
Journal:  Neuropsychopharmacology       Date:  2010-08-25       Impact factor: 7.853

6.  Inhibitors of catechol-O-methyltransferase sensitize mice to pain.

Authors:  O Kambur; R Talka; O B Ansah; V K Kontinen; A Pertovaara; E Kalso; P T Männistö
Journal:  Br J Pharmacol       Date:  2010-12       Impact factor: 8.739

7.  COMT influences on prefrontal and striatal blood oxygenation level-dependent responses during working memory among individuals with schizophrenia, their siblings, and healthy controls.

Authors:  Alan Ceaser; John G Csernansky; Deanna M Barch
Journal:  Cogn Neuropsychiatry       Date:  2012-10-03       Impact factor: 1.871

8.  Interaction of dopamine system genes and cognitive functions in patients with schizophrenia and their relatives and in healthy subjects from the general population.

Authors:  M V Alfimova; V E Golimbet; I K Gritsenko; T V Lezheiko; L I Abramova; M A Strel'tsova; I V Khlopina; R Ebstein
Journal:  Neurosci Behav Physiol       Date:  2007-09

Review 9.  Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitors.

Authors:  José A Apud; Daniel R Weinberger
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

10.  Expression of catechol-O-methyltransferase in the brain and periphery of normal and MPTP-treated common marmosets.

Authors:  Bai-Yun Zeng; Robert H Balfour; Mike J Jackson; Sarah Rose; Peter Jenner
Journal:  J Neural Transm (Vienna)       Date:  2009-09-22       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.